Related Experiment Video
Updated: Jun 4, 2026
07:34
Minimally-invasive Technique for Injection into Rat Optic Nerve
Published on: May 19, 2015
Management of ischemic optic neuropathies.
1Department of Ophthalmology and Visual Sciences, College of Medicine, University of Iowa, Iowa City, IA, USA. sohan-hayreh@uiowa.edu
Indian Journal of Ophthalmology
|February 26, 2011
Summary
Ischemic optic neuropathies (IONs) are classified into anterior (AION) and posterior (PION) types. Prompt diagnosis and high-dose steroid treatment are crucial for arteritic forms (A-AION, A-PION) and beneficial for non-arteritic PION (NA-PION) and non-arteritic AION (NA-AION).
Area of Science:
- Ophthalmology
- Neurology
- Vascular Medicine
Background:
- Ischemic optic neuropathies (IONs) encompass anterior (AION) and posterior (PION) forms, each with distinct subtypes.
- These subtypes include arteritic (A-AION, A-PION) and non-arteritic (NA-AION, NA-PION) presentations, along with surgical PION.
Purpose of the Study:
- To delineate the distinct clinical, etiological, and pathogenetic characteristics of the five ION subtypes.
- To outline optimal management strategies for each ION subtype, emphasizing timely intervention.
Main Methods:
- Review and synthesis of existing literature on the classification and management of IONs.
- Analysis of clinical presentations, diagnostic criteria, and treatment outcomes for AION and PION subtypes.
Main Results:
- Arteritic AION (A-AION) and arteritic PION (A-PION) are ophthalmic emergencies requiring immediate high-dose steroid therapy.
- Systemic corticosteroids show significant visual outcome improvement in non-arteritic AION (NA-AION) and non-arteritic PION (NA-PION) when administered early.
- No effective treatment exists for surgical PION; prevention through prophylactic measures is key.
Conclusions:
- Accurate differentiation of ION subtypes is critical for effective management.
- Early and appropriate treatment, particularly high-dose steroids for arteritic and early non-arteritic forms, can significantly improve visual prognosis.
- Management strategies must be tailored to the specific etiology and clinical presentation of each ION subtype.
Related Concept Videos
01:27Open Angle Glaucoma: Treatment
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
01:28Angle Closure Glaucoma: Treatment
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
01:25Glaucoma: Overview
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
01:27Diabetic Retinopathy
DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
01:23Atherosclerosis IV: Nursing Management
Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...